tradingkey.logo

ReShape Lifesciences Inc

RSLS

3.920USD

0.000
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
10.29MCap. mercado
PérdidaP/E TTM

ReShape Lifesciences Inc

3.920

0.000
Más Datos de ReShape Lifesciences Inc Compañía
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Información de la empresa
Símbolo de cotizaciónRSLS
Nombre de la empresaReShape Lifesciences Inc
Fecha de salida a bolsaOct 06, 2016
Director ejecutivoMr. Paul F. Hickey
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 06
Dirección1001 Calle Amanecer
CiudadSAN CLEMENTE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92673
Teléfono19494296680
Sitio Webhttps://www.reshapelifesciences.com/obalon/
Símbolo de cotizaciónRSLS
Fecha de salida a bolsaOct 06, 2016
Director ejecutivoMr. Paul F. Hickey
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
931.00K
83.65%
Europe
98.00K
8.81%
Australia
78.00K
7.01%
Rest of World
6.00K
0.54%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 17 de sep
Actualizado: mié., 17 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BMO Nesbitt Burns Inc.
0.04%
UBS Financial Services, Inc.
0.04%
Leonite Fund I LP
0.04%
FirstFire Global Opportunities Fund LLC
0.04%
Bigger Capital Funds, LP
0.03%
Otro
99.82%
Accionistas
Accionistas
Proporción
BMO Nesbitt Burns Inc.
0.04%
UBS Financial Services, Inc.
0.04%
Leonite Fund I LP
0.04%
FirstFire Global Opportunities Fund LLC
0.04%
Bigger Capital Funds, LP
0.03%
Otro
99.82%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
0.09%
Corporation
0.08%
Hedge Fund
0.06%
Individual Investor
0.02%
Otro
99.76%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
34
270.50K
11.34%
+257.74K
2025Q1
42
35.95K
1.85%
+23.58K
2024Q4
36
92.62K
3.05%
+33.67K
2024Q3
40
51.79K
41.95%
-7.67K
2024Q2
37
52.29K
38.14%
-3.61K
2024Q1
40
50.20K
37.62%
-6.41K
2023Q4
40
53.11K
38.38%
+43.81K
2023Q3
41
10.13K
39.05%
+5.49K
2023Q2
42
5.11K
36.27%
+1.18K
2023Q1
51
5.76K
66.25%
+4.13K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
UBS Financial Services, Inc.
2.23K
0.09%
+1.52K
+214.99%
Mar 31, 2025
Leonite Fund I LP
8.00K
0.34%
+8.00K
--
Feb 18, 2025
FirstFire Global Opportunities Fund LLC
8.00K
0.34%
+8.00K
--
Feb 18, 2025
Bigger Capital Funds, LP
6.40K
0.27%
+6.40K
--
Feb 18, 2025
District 2 Capital LP
6.40K
0.27%
+6.40K
--
Feb 18, 2025
Schneid (Yair)
1.50K
0.06%
-201.00
-11.84%
Sep 23, 2024
Dominion Capital LLC
1.01K
0.04%
--
--
Feb 18, 2025
Tower Research Capital LLC
389.00
0.02%
+355.00
+1044.12%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Fecha
Tipo
Relación
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Jun 15, 2021
Merger
3→1
Jun 15, 2021
Merger
3→1
Ver más
KeyAI